Citation: F. Alarcon et al., DOES COMBINED LEVODOPA AND BROMOCRIPTINE THERAPY IN PARKINSONS-DISEASE PREVENT LATE MOTOR COMPLICATIONS, European journal of neurology, 5(3), 1998, pp. 255-263
Authors:
BENSHLOMO Y
CHURCHYARD A
HEAD J
HURWITZ B
OVERSTALL P
OCKELFORD J
LEES AJ
Citation: Y. Benshlomo et al., INVESTIGATION BY PARKINSONS-DISEASE RESEARCH GROUP OF UNITED-KINGDOM INTO EXCESS MORTALITY SEEN WITH COMBINED LEVODOPA AND SELEGILINE TREATMENT IN PATIENTS WITH EARLY MILD PARKINSONS-DISEASE - FURTHER RESULTS OF RANDOMIZED TRIAL AND CONFIDENTIAL INQUIRY, BMJ. British medical journal, 316(7139), 1998, pp. 1191-1196
Authors:
BROOKS DJ
ABBOTT RJ
LEES AJ
MARTIGNONI E
PHILCOX DV
RASCOL O
ROOS RAC
SAGAR HJ
Citation: Dj. Brooks et al., A PLACEBO-CONTROLLED EVALUATION OF ROPINIROLE, A NOVEL D-2 AGONIST, AS SOLE DOPAMINERGIC THERAPY IN PARKINSONS-DISEASE, Clinical neuropharmacology, 21(2), 1998, pp. 101-107
Citation: Aj. Lees et P. Martinezmartin, QUALITY-OF-LIFE IN PARKINSONS-DISEASE AT THE PAN-EUROPEAN SYMPOSIUM IN MARBELLA, MAY 24, 1997, Journal of neurology, 245, 1998, pp. 1-1
Citation: N. Turjanski et al., DOPAMINERGIC DYSFUNCTION IN PATIENTS WITH RESTLESS LEGS - [F-18] DOPAAND [C-11] RACLOPRIDE PET STUDIES, Neurology, 50(4), 1998, pp. 6049-6049
Authors:
PICCINI PP
LEES AJ
DEYEBENES JG
PRAMSTALLER PP
TURJANSKI N
BROOKS DJ
Citation: Pp. Piccini et al., F-18 DOPA AND (18)FDG STUDIES IN 3 KINDREDS WITH FAMILIAL PROGRESSIVESUPRANUCLEAR PALSY, Neurology, 50(4), 1998, pp. 65006-65006
Authors:
COLOSIMO C
MERELLO M
HUGHES AJ
SIERADZAN K
LEES AJ
Citation: C. Colosimo et al., APOMORPHINE RESPONSES IN PARKINSONS-DISEASE AND THE PATHOGENESIS OF MOTOR COMPLICATIONS, Neurology, 50(2), 1998, pp. 573-574
Authors:
SCHRAG A
KINGSLEY D
PHATOUROS C
MATHIAS CJ
LEES AJ
DANIEL SE
QUINN NP
Citation: A. Schrag et al., CLINICAL USEFULNESS OF MAGNETIC-RESONANCE-IMAGING IN MULTIPLE SYSTEM ATROPHY, Journal of Neurology, Neurosurgery and Psychiatry, 65(1), 1998, pp. 65-71
Citation: A. Colzi et al., CONTINUOUS SUBCUTANEOUS WAKING DAY APOMORPHINE IN THE LONG-TERM TREATMENT OF LEVODOPA-INDUCED INTERDOSE DYSKINESIAS IN PARKINSONS-DISEASE, Journal of Neurology, Neurosurgery and Psychiatry, 64(5), 1998, pp. 573-576
Citation: Mk. Houser et al., FURTHER-STUDIES USING HIGHER DOSES OF BOTULINUM TOXIN TYPE-F FOR TORTICOLLIS RESISTANT TO BOTULINUM TOXIN TYPE-A, Journal of Neurology, Neurosurgery and Psychiatry, 64(5), 1998, pp. 577-580
Authors:
SPENCER JPE
JENNER P
DANIEL SE
LEES AJ
MARSDEN DC
HALLIWELL B
Citation: Jpe. Spencer et al., CONJUGATES OF CATECHOLAMINES WITH CYSTEINE AND GSH IN PARKINSONS-DISEASE - POSSIBLE MECHANISMS OF FORMATION INVOLVING REACTIVE OXYGEN SPECIES, Journal of neurochemistry, 71(5), 1998, pp. 2112-2122
Citation: Ce. Borja et al., QUANTITATIVE PHOTOCHEMISTRY OF (ETA(5)-C5H5)FE(CO)(2)I IN SOLUTION - EFFECTIVE HETEROLYTIC FE-I DISSOCIATION UPON LONG-WAVELENGTH EXCITATION, Inorganic chemistry, 37(9), 1998, pp. 2281-2284
Citation: Rs. Panesar et al., WAVELENGTH-DEPENDENT PHOTOCHEMISTRY OF W(CO)(4)(EN) (EN = ETHYLENEDIAMINE) - EVIDENCE FOR DISTINCT CHEMICAL REACTIVITIES FROM SINGLET AND TRIPLET LIGAND-FIELD EXCITED-STATES, Inorganic chemistry, 37(7), 1998, pp. 1648
Authors:
SAMUEL M
CAPUTO E
BROOKS DJ
SCHRAG A
SCARAVILLI T
BRANSTON NM
ROTHWELL JC
MARSDEN CD
THOMAS DGT
LEES AJ
QUINN NP
Citation: M. Samuel et al., A STUDY OF MEDIAL PALLIDOTOMY FOR PARKINSONS-DISEASE - CLINICAL OUTCOME, MRI LOCATION AND COMPLICATIONS, Brain, 121, 1998, pp. 59-75
Citation: N. Turjanski et al., PARKINSONISM ASSOCIATED WITH ACUTE INTRACRANIAL HEMATOMAS - AN [F-18]DOPA POSITRON-EMISSION-TOMOGRAPHY STUDY, Movement disorders, 12(6), 1997, pp. 1035-1038
Authors:
DAVIE CA
BARKER GJ
MACHADO C
MILLER DH
LEES AJ
Citation: Ca. Davie et al., PROTON MAGNETIC-RESONANCE SPECTROSCOPY IN STEELE-RICHARDSON-OLSZEWSKI-SYNDROME, Movement disorders, 12(5), 1997, pp. 767-771